|
CDC42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.861200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.012100E-02 |
| Normal-vs-Stage2 |
2.480000E-03 |
| Normal-vs-Stage3 |
2.131900E-02 |
| Normal-vs-Stage4 |
1.500700E-03 |
| Stage1-vs-Stage2 |
5.208400E-02 |
| Stage1-vs-Stage3 |
3.598800E-01 |
| Stage1-vs-Stage4 |
4.039900E-02 |
| Stage2-vs-Stage3 |
2.638600E-01 |
| Stage2-vs-Stage4 |
9.690800E-01 |
| Stage3-vs-Stage4 |
2.314400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.784300E-02 |
| Normal-vs-AfricanAmerican |
7.183800E-01 |
| Normal-vs-Asian |
3.854300E-02 |
| Caucasian-vs-AfricanAmerican |
3.384600E-01 |
| Caucasian-vs-Asian |
6.456400E-01 |
| AfricanAmerican-vs-Asian |
2.791000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.115700E-03 |
| Normal-vs-Female |
1.464030E-02 |
| Male-vs-Female |
5.162800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.305200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.981100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.579680E-03 |
| Normal-vs-Age(81-100Yrs) |
8.001200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.336000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.242100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.574200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.750000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.605000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.442800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.407600E-01 |
| Classical-VS-Follicular |
4.40390000000512E-06 |
| Classical-VS-Other |
1.098430E-01 |
| Classical-VS-Normal |
2.864200E-01 |
| Tall-VS-Follicular |
6.004200E-02 |
| Tall-VS-Other |
2.666000E-01 |
| Tall-VS-Normal |
1.337240E-01 |
| Follicular-VS-Other |
9.302600E-01 |
| Follicular-VS-Normal |
6.11999999999835E-05 |
| Other-VS-Normal |
3.062100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.783200E-04 |
| Normal-vs-N1 |
8.720600E-03 |
| N0-vs-N1 |
7.712200E-01 |
|
|
